|
시장보고서
상품코드
2075448
의약품 CSO(Contract Sales Outsourcing) 시장 : 서비스 유형별, 치료 영역별, 최종사용자별, 지역별Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Service Type, By Therapeutic Area, By End User, By Geography |
||||||
세계의 의약품 CSO(Contract Sales Outsourcing) 시장은 2026년에 116억 9,450만 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 213억 7,800만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 9.0%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 116억 9,450만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 9.00% | 2033년 시장 규모 예측 : | 213억 7,800만 달러 |
전 세계 의약품 판매 대행(CSO) 시장은 최근 유망한 성장세를 보이고 있습니다. 제약사는 의약품 연구개발에 주력하기 위해 판매 및 마케팅 업무를 전문 CSO 업체에 위탁하는 경향이 강해지고 있습니다. CSO 기업은 제약사에 대해 판매 업무의 최적화, 영업 담당자의 방문 관리, 그리고 규제 지침을 준수하는 판촉 활동의 확보를 지원하고 있습니다. 또한 데이터에 기반한 인사이트와 기술적 솔루션을 활용하여 영업 담당자의 업무 효율성을 높이고, 의사와의 접점을 확대하고 있습니다. 이러한 아웃소싱 모델을 통해 제약 기업은 높은 고정비를 부담하지 않고도 전문적인 노하우를 활용하여 업무 효율성을 높일 수 있습니다. 이러한 비용 대비 효과가 높은 접근 방식은 상업화 활동의 효율화를 목표로 하는 바이오의약품 기업 사이에서 지지를 얻고 있습니다.
시장 역학 :
전 세계 의약품 CSO(Contract Sales Outsourcing) 시장은 바이오의약품 기업이 판매 비용을 최적화하고 생산성을 향상시켜야 할 필요성 등의 요인에 힘입어 성장하고 있습니다. 특히 미국내 의약품 판촉 규제가 복잡해진 점도 제약 기업이 규정 준수 체계에 정통한 전문 CSO 제공업체에 판매 업무를 위탁하는 한 가지 원인이 되고 있습니다. 또한 고객 관계 관리(CRM) 및 데이터 분석 분야의 기술 발전이 영업 업무 아웃소싱 수요 증가로 이어지고 있습니다. 그러나 의약품 가격 환경의 변동이나 특정 지역의 불리한 의료제도 개혁은 시장 참여자들에게 과제가 되고 있습니다. 또한 CSO 업계의 재편은 고객과의 관계에 영향을 미치고 있습니다. 새로운 기회로는 기존과는 다른 치료 분야로의 진출 및 시장 접근과 관련된 부가가치 서비스 제공을 들 수 있습니다.
기업이 영업 프로세스를 합리화하고 효율성을 높일 필요성이 커지고 있는 것은 영업 계획 및 실적 분석 소프트웨어에 대한 수요를 더욱 촉진할 것입니다. 예를 들어 2025년 11월 7일, 디지털 기술 기업인 액센츄어와 소프트웨어 기업인 세일즈포스 닷 인크는 생명과학 기업을 대상으로 인공지능(AI)을 활용한 클라우드 서비스를 구축하기 위한 제휴를 발표했습니다. 이번 제휴를 통해 액센츄어는 생의학 연구 업계와 인공지능 기술 두 분야 모두에서 자사가 보유한 전문 지식을 "Salesforce Life Sciences Cloud'에 통합되어, 의료 기술, 생명공학, 제약 기업의 효율화를 도모한다는 이 새로운 소프트웨어의 사명을 실현하는 데 기여하게 되었습니다.
본 조사의 주요 특징 :
- 이 조사에서는 다양한 부문의 잠재적 성장 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하고 있는 경쟁 전략에 관한 중요 인사이트도 제공하고 있습니다.
- 이 조사에서는 다음의 파라미터(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로, 전 세계 제약 CSO(Contract Sales Outsourcing) 시장의 주요 기업 개요을 소개하고 있습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 이 '세계의 의약품 CSO(Contract Sales Outsourcing) 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 제약 CSO(Contract Sales Outsourcing) 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 원활하게 의사결정을 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 의약품 CSO(Contract Sales Outsourcing) 시장 : 서비스 유형별, 2021-2033년
제5장 세계의 의약품 CSO(Contract Sales Outsourcing) 시장 : 치료 영역별, 2021-2033년
제6장 세계의 의약품 CSO(Contract Sales Outsourcing) 시장 : 최종사용자별, 2021-2033년
제7장 세계의 의약품 CSO(Contract Sales Outsourcing) 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
KSA 26.07.08Global Pharmaceutical Contract Sales Outsourcing (CSO) Market is estimated to be valued at USD 11,694.5 Mn in 2026 and is expected to reach USD 21,378.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 11,694.5 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.00% | 2033 Value Projection: | USD 21,378.0 Mn |
The global pharmaceutical contract sales outsourcing (CSO) market has shown promising growth in recent years. Pharmaceutical manufacturers are increasingly outsourcing their sales and marketing operations to specialized CSO providers in order to focus on drug research and development. CSO firms assist drug makers in optimizing sales operations, managing representative visits, and ensuring promotional compliance with regulatory guidelines. They leverage data-driven insights and technological solutions to enhance sales representative effectiveness and expand physician reach. The outsourcing model enables pharmaceutical companies to access specialized expertise and achieve operational efficiencies without incurring high fixed costs. This cost-effective approach has thus gained traction among biopharma firms looking to streamline commercialization activities.
Market Dynamics:
The global pharmaceutical contract sales outsourcing (CSO) market is driven by factors such as the need of biopharma players to optimize sales costs and boost productivity. Growing complexity of drug promotion regulations particularly in the U.S. also prompts pharmaceutical companies to outsource sales operations to specialized CSO providers well-versed with compliance frameworks. Additionally, technological advancements in customer relationship management and data analytics are translating into increased demand for outsourced sales capabilities. However, volatility in drug pricing environments and unfavorable healthcare reforms in certain regions pose challenges to market players. Furthermore, consolidation in the CSO industry landscape impacts client relationships. Emerging opportunities lie in expansion into non-traditional therapeutic areas and offering value-added services around market access.
Increasing requirement for companies to streamline the sales process and achieve higher efficiency will further aid in the demand for sales planning/performance analytics software. For instance, on November 7, 2025, Accenture, a digital technology company, and Salesforce, Inc., a software company, announced the collaboration to build an Artificial intelligence (AI) powered cloud service for life sciences companies. Under the collaborations, Accenture added its own expertise both in the biomedical research industry and in artificial intelligence technologies to the Salesforce Life Sciences Cloud to help fulfill the new software's mission of making medtech, biotech, and pharma companies more efficient.
Key Features of the Study:
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global pharmaceutical contract sales outsourcing (CSO) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include IQVIA Inc., Syneos Health Inc., Parexel International Corporation, PPD, ICON plc, Publicis Touchpoint Solutions, Inc., PRA Health Sciences, Inc., The Medical Affairs Company (TMAC), Ashfield Healthcare Communications Group, and GTS Solutions
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global pharmaceutical contract sales outsourcing (CSO) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmaceutical contract sales outsourcing (CSO) market
Detailed Segmentation:
- Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Service Type (Revenue, USD Mn, 2021 - 2033)
- Personal Promotion
- Non-personal Promotion
- Others
- Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Therapeutic Area (Revenue, USD Mn, 2021 - 2033)
- Cardiovascular Disorders
- Oncology
- Metabolic Disorders
- Neurology
- Orthopedic Diseases
- Infectious Diseases
- Others
- Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By End User (Revenue, USD Mn, 2021 - 2033)
- Biopharmaceutical Companies
- Medical Device Companies
- Generic Companies
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Top Companies in the Global Pharmaceutical Contract Sales Outsourcing (CSO) Market:
- IQVIA Inc.
- Syneos Health Inc.
- Parexel International Corporation
- PPD
- ICON plc
- Publicis Touchpoint Solutions, Inc.
- PRA Health Sciences, Inc.
- The Medical Affairs Company (TMAC)
- Ashfield Healthcare Communications Group
- GTS Solutions
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Service Type
- Market Snippet, By Therapeutic Area
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Digital technology adoption
- Access to care disparities
- Population health initiatives
- Key Highlights
- Regulatory Scenario
- Recent Trends
- PEST Analysis
- PORTER's Analysis
- Mergers, Acquisitions, and Collaborations
4. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Service Type, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Personal Promotion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Non-personal Promotion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
5. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Therapeutic Area, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Cardiovascular Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Metabolic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Orthopedic Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
6. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By End User, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Medical Device Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Generic Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
7. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Region, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022 - 2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Mn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profile
- IQVIA Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Syneos Health Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Parexel International Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- PPD
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- ICON plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Publicis Touchpoint Solutions, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Strategies
- PRA Health Sciences, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- The Medical Affairs Company (TMAC)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Ashfield Healthcare Communications Group
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GTS Solutions
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- IQVIA Inc.
- Analyst Views
9. Section
- References
- Research Methodology
- About us
